Ciprofloxacin

Paul G. Auwaerter, M.D., Edina Avdic, Pharm.D.

INDICATIONS

FDA

  • Ophthalmic
    • Bacterial conjunctivitis (ophthalmic ointment and solution) due to susceptible organisms [Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans Group, and Haemophilus influenzae]
  • Otic
    • Acute otitis externa(Ciprodexotic suspension) with tympanostomy tubes: infants ≥6 months, children, and adolescents
    • Tympanostomy tube treatment (Otovel) prevention of excess fluid in the middle ear, and treatment of acute otitis media with tympanostomy tubes (AOMT) by certain bacteria
    • Treatment of acute otitis externa (Cetraxal) due to susceptible Pseudomonas aeruginosa or Staphylococcus aureus isolates.

NON-FDA APPROVED USES

Partial listing

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 12, 2023